Company: SCLXW
Filing Date: 2025-05-07
Form Type: POS AM
Source: 0001193125-25-115095
Chunk: 16

Company: Scilex Holding Co
Filing Date: 2025-05-07
Form: POS AM
Chunk 16
---
 and listing standards of Nasdaq. |

| • |     | “October 2024 Noteholder Warrants” means the warrants to purchase up to an aggregate of 214,284 shares of our Common Stock, with a current exercise price of $36.40 per share, issued to the Tranche B Noteholders. |

| • |     | “October 2024 Placement Agent Warrants” means the warrants to purchase up to an aggregate of 104,848 shares of Common Stock, with a current exercise price of $36.40 per share, issued to StockBlock and Rodman & Renshaw LLC in connection with the Tranche B Securities Purchase Agreement. |

| • |     | “October 2024 Warrants” means the October 2024 Noteholder Warrants and the October 2024 Placement Agent Warrants. |

| • |     | “Oramed” means Oramed Pharmaceuticals Inc., a Delaware corporation. |

| • |     | “Oramed Note” means that certain senior secured promissory note issued by us on September 21, 2023 to Oramed due 18 months from the date of issuance in the principal amount of $101,875,000. |

| • |     | “Penny Warrants” means the warrants to purchase up to an aggregate of 13,000,000 shares of our Common Stock, each with an exercise price of $0.01 per share, issued to Oramed pursuant to the Scilex-Oramed SPA. |

| • |     | “Private Warrants” means the 6,840,000 warrants sold in a private placement to Vickers Venture Fund VI Pte Ltd and Vickers Venture Fund VI (Plan) Pte Ltd consummated on January 11, 2021 (of which 2,736,000 were forfeited pursuant to the Sponsor Support Agreement and 3,104,000 were transferred to Sorrento pursuant to the Warrant Transfer Agreement, in each case in connection with the Business Combination). |

6

| • |     | “public shareholders” means the holders of the public shares. |

| • |     | “public shares” means the Vickers Ordinary Shares which were sold as part of the IPO, whether they were purchased in the IPO or in the aftermarket, including any of our Initial Shareholders to the extent that they purchase such public shares (except that our Initial Shareholders will not have conversion or tender rights with respect to any public shares they